Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Trabectedin fails to improve survival outcomes in recurrent ovarian, primary peritoneal, or fallopian tube cancer

Trabectedin fails to improve survival outcomes in recurrent ovarian, primary peritoneal, or fallopian tube cancer

07 Sep 2022
IV, SC doses of biologic combo effective in asymptomatic, low-risk COVID-19 patients

IV, SC doses of biologic combo effective in asymptomatic, low-risk COVID-19 patients

07 Sep 2022
Levonorgestrel-releasing intrauterine system reduces pelvic pain but may increase expulsion risk

Levonorgestrel-releasing intrauterine system reduces pelvic pain but may increase expulsion risk

06 Sep 2022

In the treatment of patients with organic disease and heavy menstrual bleeding and/or dysmenorrhea, the use of levonorgestrel-releasing intrauterine system (LNG-IUS) attenuates chronic pelvic pain, according to a study. However, it appears to confer an increased risk of expulsion for some women.

Levonorgestrel-releasing intrauterine system reduces pelvic pain but may increase expulsion risk

06 Sep 2022